Neoplasm by Histologic Type

Also known as: Neoplasms by Histologic Type / Neoplasm by Histology

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB11595	Atezolizumab	1	Terminated	1
DB15722	CYNK-001	1	Active Not Recruiting	1
DB15722	CYNK-001	1	Recruiting	1
DB00958	Carboplatin	1	Terminated	1
DB00987	Cytarabine	1	Recruiting	1
DB01234	Dexamethasone	1	Completed	1
DB00997	Doxorubicin	1	Completed	1
DB11841	Entinostat	1	Completed	2
DB00099	Filgrastim	1	Recruiting	1
DB01073	Fludarabine	1	Recruiting	1
DB05827	G207	1	Active Not Recruiting	1
DB12141	Gilteritinib	1	Recruiting	1
DB01177	Idarubicin	1	Recruiting	1
DB12005	Nirogacestat	1	Completed	1
DB17280	OriCar-017	1	Not Yet Recruiting	1
DB09330	Osimertinib	1	Terminated	1
DB09037	Pembrolizumab	1	Completed	1
DB00642	Pemetrexed	1	Terminated	1
DB04974	Rimiducid	1	Active Not Recruiting	1
DB01268	Sunitinib	1	Terminated	1
DB05109	Trabectedin	1	Completed	1
DB11930	Varlilumab	1	Terminated	2
DB17171	Ziftomenib	1	Recruiting	1
DB00958	Carboplatin	1 / 2	Active Not Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Not Yet Recruiting	1
DB01073	Fludarabine	1 / 2	Not Yet Recruiting	1
DB09330	Osimertinib	1 / 2	Active Not Recruiting	1
DB17129	Pelabresib anhydrous	1 / 2	Active Not Recruiting	1
DB00642	Pemetrexed	1 / 2	Active Not Recruiting	1
DB15822	Pralsetinib	1 / 2	Completed	1
DB08877	Ruxolitinib	1 / 2	Active Not Recruiting	1
DB16750	THE-630	1 / 2	Active Not Recruiting	1
DB17473	APL-502	2	Recruiting	1
DB00316	Acetaminophen	2	Not Yet Recruiting	1
DB11885	Anlotinib	2	Not Yet Recruiting	1
DB11885	Anlotinib	2	Recruiting	2
DB00112	Bevacizumab	2	Recruiting	1
DB00112	Bevacizumab	2	Unknown Status	1
DB00188	Bortezomib	2	Not Yet Recruiting	1
DB00958	Carboplatin	2	Not Yet Recruiting	1
DB00531	Cyclophosphamide	2	Not Yet Recruiting	1
DB01234	Dexamethasone	2	Not Yet Recruiting	2
DB01075	Diphenhydramine	2	Not Yet Recruiting	1
DB00441	Gemcitabine	2	Not Yet Recruiting	1
DB14811	Isatuximab	2	Not Yet Recruiting	2
DB00480	Lenalidomide	2	Not Yet Recruiting	2
DB16582	Lisocabtagene maraleucel	2	Completed	1
DB11793	Niraparib	2	Unknown Status	1
DB09074	Olaparib	2	Recruiting	1
DB00526	Oxaliplatin	2	Not Yet Recruiting	1
DB01229	Paclitaxel	2	Not Yet Recruiting	1
DB09073	Palbociclib	2	Recruiting	1
DB09037	Pembrolizumab	2	Completed	1
DB16747	Penpulimab	2	Not Yet Recruiting	1
DB08910	Pomalidomide	2	Not Yet Recruiting	1
DB00863	Ranitidine	2	Not Yet Recruiting	1
DB00073	Rituximab	2	Not Yet Recruiting	1
DB17178	Tasadenoturev	2	Completed	1
DB06334	Tucidinostat	2	Unknown Status	1
DB11363	Alectinib	2 / 3	Recruiting	1
DB11595	Atezolizumab	2 / 3	Recruiting	1
DB11986	Entrectinib	2 / 3	Recruiting	1
DB04690	Camptothecin	3	Terminated	1
DB00958	Carboplatin	3	Active Not Recruiting	1
DB00515	Cisplatin	3	Active Not Recruiting	1
DB00441	Gemcitabine	3	Active Not Recruiting	1
DB00762	Irinotecan	3	Terminated	1
DB06080	Linifanib	3	Terminated	1
DB01229	Paclitaxel	3	Active Not Recruiting	1
DB09037	Pembrolizumab	3	Active Not Recruiting	1
DB00642	Pemetrexed	3	Active Not Recruiting	1
DB15822	Pralsetinib	3	Active Not Recruiting	1
DB00398	Sorafenib	3	Terminated	1
DB00853	Temozolomide	3	Terminated	1
DB00515	Cisplatin	Not Available	Recruiting	1
DB14554	Dotatate	Not Available	Recruiting	1
DB13985	Lutetium Lu 177 dotatate	Not Available	Recruiting	1
DB12172	Nimorazole	Not Available	Recruiting	1
DB17097	Vorasidenib	Not Available	Available	1